References

  1. Biedermann T, Winther L, Till SJ, Panzner P, Knulst A, Valovirta E. Birch pollen allergy in Europe. Allergy. 2019A Jul;74(7):1237-1248.
  2. Chan‐Yeung M, Anthonisen NR, Becklake MR, Bowie D, Sonia Buist A, Dimich‐Ward H, et al. Geographical variations in the prevalence of atopic sensitization in six study sites across Canada. Allergy  2010;65:1404–1413.
  3. Valcour A, Jones JE, Lidholm J, Borres MP, Hamilton RG. Sensitization profiles to peanut allergens across the United States. Ann Allergy Asthma Immunol. 2017 Sep;119(3):262-266.e1.
  4. Smith M, Jäger S, Berger U, Sikoparija B, Hallsdottir M, Sauliene I, et al. Geographic and temporal variations in pollen exposure across Europe. Allergy. 2014 Jul;69(7):913-23.
  5. Canova C, Heinrich J, Anto JM, Leynaert B, Smith M, Kuenzli N, et al. The influence of sensitization to pollens and moulds on seasonal variations in asthma attacks. Eur Respir J . 2013;42:935‐945.
  6. Caillaud DM, Martin S, Segala C, et al. Airborne pollen levels and drug consumption for seasonal allergic rhinoconjunctivitis: a 10‐year study in France. Allergy . 2015;70:99‐106.
  7. James C, Bernstein DI. Allergen immunotherapy: an updated review of safety.
Curr Opin Allergy Clin Immunol. 2017 Feb;17(1):55-59.
  1. Bernstein DI, Epstein TEG. Safety of allergen immunotherapy in North America from 2008-2017: Lessons learned from the ACAAI/AAAAI National Surveillance Study of adverse reactions to allergen immunotherapy. Allergy Asthma Proc. 2020 Mar 1;41(2):108-111.
  2. Passalacqua G, Nowak-Węgrzyn A, Canonica GW. Local Side Effects of Sublingual and Oral Immunotherapy. J Allergy Clin Immunol Pract. 2017 Jan - Feb;5(1):13-21.
  3. European Academy of Allergy and Clinical Immunology (EAACI) guidelines 2017: Allergen Immunotherapy Guidelines Part 2: Recommendations. Muraro A and Roberts G, eds. Zürich, Switzerland.
  4. Bernstein DI, Bardelas JA Jr, Svanholm Fogh B, Kaur A, Li Z, Nolte H. A practical guide to the sublingual immunotherapy tablet adverse event profile: implications for clinical practice. Postgrad Med. 2017 Aug;129(6):590-597.
  5. Geroldinger-Simic M, Zelniker T, Aberer W, Ebner C, Egger C, Greiderer A, et al. Birch pollen-related food allergy: clinical aspects and the role of allergen-specific IgE and IgG4 antibodies. J Allergy Clin Immunol. 2011 Mar;127(3):616-22.e1.
  6. Biedermann T, Kuna P, Panzner P, Valovirta E, Andersson M, de Blay F, et al. The SQ tree SLIT-tablet is highly effective and well tolerated: Results from a randomized, double-blind, placebo-controlled phase III trial. J Allergy Clin Immunol. 2019B Mar;143(3):1058-1066.
  7. Mäkelä MJ, Gyllfors P, Valovirta E, et al. Immunotherapy With the SQ Tree SLIT-tablet in Adults and Adolescents With Allergic Rhinoconjunctivitis. Clin Ther . 2018;40(4):574-586.e4.
  8. Couroux P, Ipsen H, Stage BS, et al. A birch sublingual allergy immunotherapy tablet reduces rhinoconjunctivitis symptoms when exposed to birch and oak and induces IgG4 to allergens from all trees in the birch homologous group. Allergy . 2019;74(2):361-369.
  9. Maloney J, Bernstein DI, Nelson H, Creticos P, Hébert J, Noonan M, et al. Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial. Ann Allergy Asthma Immunol. 2014 Feb;112(2):146-153.
  10. Halken S, Roberts G, Valovirta E, Nolte H, Hulstrøm V, Blaiss MS. Safety of Timothy Grass Sublingual Immunotherapy Tablet in Children: Pooled Analyses of Clinical Trials. J Allergy Clin Immunol Pract. 2020 Apr;8(4):1387-1393.
  11. Klimek L, Mosbech H, Zieglmayer P, Rehm D, Stage BS, Demoly P. SQ house dust mite (HDM) SLIT-tablet provides clinical improvement in HDM-induced allergic rhinitis. Expert Rev Clin Immunol. 2016;12(4):369-377.
  12. Muraro A, Werfel T, Hoffmann-Sommergruber K, Roberts G, Beyer K,
Bindslev-Jensen C, Cardona V, et al.; EAACI Food Allergy and Anaphylaxis Guidelines Group. EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy. 2014 Aug;69(8):1008-25.
Hesselmar B, Eriksson B, Aberg N. Urticaria is associated with birch-pollen
sensitization. Pediatr Allergy Immunol. 2007 Dec;18(8):692-5.
  1. Fölster-Holst R, Galecka J, Weißmantel S, et al. Birch pollen influence the severity of atopic eczema - prospective clinical cohort pilot study and ex vivo penetration study. Clin Cosmet Investig Dermatol. 2015 Oct 29;8:539-48.
  2. Letner D, Farris A, Khalili H, Garber J. Pollen-food allergy syndrome is a common allergic comorbidity in adults with eosinophilic esophagitis. Dis Esophagus. 2018 Feb 1;31(2).
  3. Spergel J, Aceves SS. Allergic components of eosinophilic esophagitis. J Allergy Clin
Immunol. 2018 Jul;142(1):1-8.
Durham SR, Emminger W, Kapp A, et al. SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. J Allergy Clin Immunol . 2012;129(3):717‐725.e5.